Lay Sciences
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4455 Military Trl Ste 204, Jupiter, Flor...Website
www.laysciences.comRevenue
<$5 MillionIndustry
About Lay Sciences
Lay Sciences Org Chart
Is Lay Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Lay Sciences launches new products
Funding: Get notified immidiatlly once Lay Sciences has new funding data
Website visits: Recent activity has been detected on your website
Lay Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Lay Sciences recently announced quarterly report
Check out if Lay Sciences is spiking on competitors!
Click to see if Lay Sciences had a recent Job posting/layoffs
Check if Lay Sciences has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Lay Sciences
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Lay Sciences as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Lay Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lay Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lay Sciences.
Lay Sciences Tech Stack
A closer look at the technologies used by Lay Sciences
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lay Sciences
Lay Sciences Inc. is a Florida-based company specializing in innovative treatments and prophylaxis using their novel IgY technology. They aim to provide life-saving products to patients globally, targeting previously undruggable conditions with their proprietary oral polyclonal IgY antibodies. The company has partnered with three biotech firms and... Read More